Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 19, 2021
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
Tue, May 18, 2021
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
Esther Rajavelu Initiated (STOK) at Hold and Held Target at $35 on, May 18th, 2021
Esther Rajavelu of UBS, Initiated "Stoke Therapeutics, Inc." (STOK) at Hold and Held Target at $35 on, May 18th, 2021.
Esther has made no other calls on STOK in the last 4 months.
There are 3 other peers that have a rating on STOK. Out of the 3 peers that are also analyzing STOK, 0 agree with Esther's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Esther
- Laura Chico of "Wedbush" Upgraded from Hold to Buy on, Monday, May 10th, 2021
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $76 on, Thursday, March 11th, 2021
- Martin Auster of "Credit Suisse" Maintained at Buy with Increased Target to $58 on, Wednesday, March 10th, 2021
